These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 25412655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heparin-induced thrombocytopenia (HIT) and thrombosis in a haemodialysis-dependent patient with systemic vasculitis.
    Roe SD, Cassidy MJ, Haynes AP, Byrne JL.
    Nephrol Dial Transplant; 1998 Dec; 13(12):3226-9. PubMed ID: 9870499
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP, Walenga JM.
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Persistent heparin-induced thrombocytopenia: danaparoid cross-reactivity or delayed-onset heparin-induced thrombocytopenia? A case report.
    Horlait G, Minet V, Mullier F, Michaux I.
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):193-197. PubMed ID: 27100305
    [Abstract] [Full Text] [Related]

  • 13. [Heparin-induced thrombocytopenia].
    Christoffersen C, Lethagen S, Gøtze JP.
    Ugeskr Laeger; 2009 Feb 16; 171(8):612-5. PubMed ID: 19284907
    [Abstract] [Full Text] [Related]

  • 14. Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.
    Castelino RL, Maddula M, Tarafdar S, Sud K, Kairaitis L.
    Thromb Res; 2019 Aug 16; 180():70-73. PubMed ID: 31229923
    [Abstract] [Full Text] [Related]

  • 15. Failure of danaparoid anticoagulation for cardiopulmonary bypass.
    Ariano RE, Bhattacharya SK, Moon M, Brownell LG.
    J Thorac Cardiovasc Surg; 2000 Jan 16; 119(1):167-8. PubMed ID: 10612777
    [No Abstract] [Full Text] [Related]

  • 16. [Danaparoid sodium for dialysis in heparin-associated thrombocytopenia].
    Ben Ami R, Rachmimov R, Berliner S.
    Harefuah; 1999 Mar 01; 136(5):361-4, 419. PubMed ID: 10914239
    [Abstract] [Full Text] [Related]

  • 17. Anticoagulative management of patients requiring left ventricular assist device implantation and suffering from heparin-induced thrombocytopenia type II.
    Christiansen S, Jahn UR, Meyer J, Scheld HH, Van Aken H, Kehrel BE, Hammel D.
    Ann Thorac Surg; 2000 Mar 01; 69(3):774-7. PubMed ID: 10750760
    [Abstract] [Full Text] [Related]

  • 18. Management of heparin-induced thrombocytopenia during continuous renal replacement therapy.
    Davenport A.
    Am J Kidney Dis; 1998 Oct 01; 32(4):E3. PubMed ID: 10074589
    [Abstract] [Full Text] [Related]

  • 19. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
    Lindhoff-Last E, Bauersachs R.
    Semin Thromb Hemost; 2002 Oct 01; 28(5):439-46. PubMed ID: 12420239
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.